UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 57

Sortiert nach

Epithelial-to-Mesenchymal Transition Leads to Docetaxel Resistance in Prostate Cancer and Is Mediated by Reduced Expression of miR-200c and miR-205

The American journal of pathology, 2012-12, Vol.181 (6), p.2188-2201

2012

Volltextzugriff (PDF)

Assessment of STAT5 as a potential therapy target in enzalutamide-resistant prostate cancer

PloS one, 2020-08, Vol.15 (8), p.e0237248

2020

Volltextzugriff (PDF)

Metabolic changes during prostate cancer development and progression

Journal of cancer research and clinical oncology, 2023-05, Vol.149 (5), p.2259-2270

2023

Volltextzugriff (PDF)

Glucocorticoid treatment influences prostate cancer cell growth and the tumor microenvironment via altered glucocorticoid receptor signaling in prostate fibroblasts

Oncogene, 2024-01, Vol.43 (4), p.235-247

2024

Volltextzugriff (PDF)

Targeting the glutamine metabolism to suppress cell proliferation in mesenchymal docetaxel-resistant prostate cancer

Oncogene, 2024-06, Vol.43 (26), p.2038-2050

2024

Volltextzugriff (PDF)

New advances of the androgen receptor in prostate cancer: report from the 1st International Androgen Receptor Symposium

Journal of translational medicine, 2024-01, Vol.22 (1), p.71-8, Article 71

2024

Volltextzugriff (PDF)

Utilization of sperm cryopreservation in patients with testicular cancer

Journal of cancer research and clinical oncology, 2024-04, Vol.150 (4), p.201-201, Article 201

2024

Volltextzugriff (PDF)

Identification of genomic drivers for the therapeutic response of Cabozantinib in patients with metastatic renal cell carcinoma

World journal of urology, 2024-02, Vol.42 (1), p.94-94, Article 94

2024

Volltextzugriff (PDF)

Acquired resistance to irradiation or docetaxel is not associated with cross-resistance to cisplatin in prostate cancer cell lines

Journal of cancer research and clinical oncology, 2022-06, Vol.148 (6), p.1313-1324

2022

Volltextzugriff (PDF)

Gelsolin Governs the Neuroendocrine Transdifferentiation of Prostate Cancer Cells and Suppresses the Apoptotic Machinery

Anticancer research, 2021-08, Vol.41 (8), p.3717-3729

2021

Volltextzugriff (PDF)

PIAS1 Is Increased in Human Prostate Cancer and Enhances Proliferation through Inhibition of p21

The American journal of pathology, 2012-05, Vol.180 (5), p.2097-2107

2012

Volltextzugriff (PDF)

Relevance of the natural HDAC inhibitor sulforaphane as a chemopreventive agent in urologic tumors

Cancer letters, 2018-10, Vol.435, p.121-126

2018

Volltextzugriff (PDF)

Comprehensive Evaluation of Multiple Approaches Targeting ABCB1 to Resensitize Docetaxel-Resistant Prostate Cancer Cell Lines

International journal of molecular sciences, 2022-12, Vol.24 (1), p.666

2022

Volltextzugriff (PDF)

Systemic Triple Therapy in Metastatic Hormone-Sensitive Prostate Cancer (mHSPC): Ready for Prime Time or Still to Be Explored?

Cancers, 2021-12, Vol.14 (1), p.8

2021

Volltextzugriff (PDF)

Impact of STAT Proteins in Tumor Progress and Therapy Resistance in Advanced and Metastasized Prostate Cancer

Cancers, 2021-09, Vol.13 (19), p.4854

2021

Volltextzugriff (PDF)

Impact of Androgen Receptor Activity on Prostate-Specific Membrane Antigen Expression in Prostate Cancer Cells

International journal of molecular sciences, 2022-01, Vol.23 (3), p.1046

2022

Volltextzugriff (PDF)

The putative tumour suppressor protein Latexin is secreted by prostate luminal cells and is downregulated in malignancy

Scientific reports, 2019-03, Vol.9 (1), p.5120-5120, Article 5120

2019

Volltextzugriff (PDF)

Glutamine Metabolism and Prostate Cancer

Cancers, 2024-08, Vol.16 (16), p.2871

2024

Volltextzugriff (PDF)

SOCS3 Modulates the Response to Enzalutamide and Is Regulated by Androgen Receptor Signaling and CpG Methylation in Prostate Cancer Cells

Molecular cancer research, 2016-06, Vol.14 (6), p.574-585

2016

Volltextzugriff (PDF)

Sorafenib decreases proliferation and induces apoptosis of prostate cancer cells by inhibition of the androgen receptor and Akt signaling pathways

Endocrine-related cancer, 2012-06, Vol.19 (3), p.305-319

2012

Volltextzugriff (PDF)

Pleiotropic Devitalization of Renal Cancer Cells by Non-Invasive Physical Plasma: Characterization of Molecular and Cellular Efficacy

Cancers, 2023-01, Vol.15 (2), p.481

2023

Volltextzugriff (PDF)

Artesunate Inhibits the Growth Behavior of Docetaxel-Resistant Prostate Cancer Cells

Frontiers in oncology, 2022-02, Vol.12, p.789284

2022

Volltextzugriff (PDF)

The Androgen Hormone-Induced Increase in Androgen Receptor Protein Expression Is Caused by the Autoinduction of the Androgen Receptor Translational Activity

Current issues in molecular biology, 2022-01, Vol.44 (2), p.597-608

2022

Volltextzugriff (PDF)

Transcript Markers from Urinary Extracellular Vesicles for Predicting Risk Reclassification of Prostate Cancer Patients on Active Surveillance

Cancers, 2024-07, Vol.16 (13), p.2453

2024

Volltextzugriff (PDF)

A Systematic Comparison of Antiandrogens Identifies Androgen Receptor Protein Stability as an Indicator for Treatment Response

Life (Basel, Switzerland), 2021-08, Vol.11 (9), p.874

2021

Volltextzugriff (PDF)

1 – 25 von 57

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(54)
Mit Volltextzugriff
(56)

Publikationsform

Sprache

Englisch
(56)
Japanisch
(8)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Epithelial-to-Mesenchymal Transition Leads to Docetaxel Resistance in Prostate Cancer and Is Mediated by Reduced Expression of miR-200c and miR-205

Assessment of STAT5 as a potential therapy target in enzalutamide-resistant prostate cancer

Metabolic changes during prostate cancer development and progression

Glucocorticoid treatment influences prostate cancer cell growth and the tumor microenvironment via altered glucocorticoid receptor signaling in prostate fibroblasts

Targeting the glutamine metabolism to suppress cell proliferation in mesenchymal docetaxel-resistant prostate cancer

New advances of the androgen receptor in prostate cancer: report from the 1st International Androgen Receptor Symposium

Utilization of sperm cryopreservation in patients with testicular cancer

Identification of genomic drivers for the therapeutic response of Cabozantinib in patients with metastatic renal cell carcinoma

Acquired resistance to irradiation or docetaxel is not associated with cross-resistance to cisplatin in prostate cancer cell lines

Gelsolin Governs the Neuroendocrine Transdifferentiation of Prostate Cancer Cells and Suppresses the Apoptotic Machinery

PIAS1 Is Increased in Human Prostate Cancer and Enhances Proliferation through Inhibition of p21

Relevance of the natural HDAC inhibitor sulforaphane as a chemopreventive agent in urologic tumors

Comprehensive Evaluation of Multiple Approaches Targeting ABCB1 to Resensitize Docetaxel-Resistant Prostate Cancer Cell Lines

Systemic Triple Therapy in Metastatic Hormone-Sensitive Prostate Cancer (mHSPC): Ready for Prime Time or Still to Be Explored?

Impact of STAT Proteins in Tumor Progress and Therapy Resistance in Advanced and Metastasized Prostate Cancer

Impact of Androgen Receptor Activity on Prostate-Specific Membrane Antigen Expression in Prostate Cancer Cells

The putative tumour suppressor protein Latexin is secreted by prostate luminal cells and is downregulated in malignancy

Glutamine Metabolism and Prostate Cancer

SOCS3 Modulates the Response to Enzalutamide and Is Regulated by Androgen Receptor Signaling and CpG Methylation in Prostate Cancer Cells

Sorafenib decreases proliferation and induces apoptosis of prostate cancer cells by inhibition of the androgen receptor and Akt signaling pathways

Pleiotropic Devitalization of Renal Cancer Cells by Non-Invasive Physical Plasma: Characterization of Molecular and Cellular Efficacy

Artesunate Inhibits the Growth Behavior of Docetaxel-Resistant Prostate Cancer Cells

The Androgen Hormone-Induced Increase in Androgen Receptor Protein Expression Is Caused by the Autoinduction of the Androgen Receptor Translational Activity

Transcript Markers from Urinary Extracellular Vesicles for Predicting Risk Reclassification of Prostate Cancer Patients on Active Surveillance

A Systematic Comparison of Antiandrogens Identifies Androgen Receptor Protein Stability as an Indicator for Treatment Response

Suchergebnisse filtern